Dr. Frederick Sancilio is a recognized leader in the field of pharmaceutical product development. The founder of aaiPharma and an experienced formulator and research scientist for more than 30 years, Dr. Sancilio has dedicated his efforts over the last decade to the study of both inflammation and pain.Over his career, he has contributed to over 20 U.S. and Foreign Patents related to new drug products and/or delivery systems.
After a successful career in pharmaceutical drug development, Dr. Sancilio decided to utilize his insight into the association between dietary deficiencies and their affect on various health related conditions to produce a line of health promoting supplements; the first of which is marine origin Omega-3.According to Dr. Sancilio, EPA and DHA which comprise the essential fatty acid known as Omega-3, is vital for the production of series III eicosanoids (Prostaglandins, Leukotrienes and Thromboxanes) which control several vital functions of the body including inflammation, clotting and breathing.Dr. Sancilio deduced that dietary supplements rich in EPA and DHA could supplement for Western civilization’s lack of these essential fatty acids.Due to the scarcity of quality supplements with the potency needed to properly control these conditions, Dr. Sancilio was compelled to return to the helm of a group of formulators to produce a supplement utilizing proven scientific techniques and appropriate concentrations of these vital materials: Ocean Blue Professional.
Dr. Sancilio has authored 20 scientific papers over the span of his pharmaceutical career; however the release of his long awaited book in 2014 is anticipated to bring clarity to the highly misunderstood role of Omega-3 in overall health and wellness.